More about
Normal Ocular Surface Disease
CME
Video
Ocular Surface and Eyelid Health: FAQs on New Treatment Options
This activity is supported by educational grants from Tarsus Pharmaceuticals, Inc.; Thea Pharma Inc.; and Viatris, Inc.
CME
Video
Optimizing Ocular Surface and Eyelid Health: Keeping an Eye on the Prize
This activity is supported by educational grants from Tarsus Pharmaceuticals, Inc.; Thea Pharma Inc.; and Viatris, Inc.
CME
Video
Ocular Surface Disease and Eyelid Health: Seeing Eye to Eye
This activity is supported by educational grants from Tarsus Pharmaceuticals, Inc. and Thea Pharma Inc.
News
January 22, 2024
2 min watch
Save
VIDEO: Perfluorohexyloctane offers new clinical tool for evaporative dry eye disease
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Laura M. Periman, MD, discusses innovations in evaporative dry eye disease.
News
November 01, 2023
1 min read
Save
Aldeyra Therapeutics, AbbVie enter option agreement to develop reproxalap
Aldeyra Therapeutics has entered into an exclusive option agreement with AbbVie for license to develop, manufacture and commercialize reproxalap, the company announced in a press release.